New section 6a permitted cannabis cultivation for obtaining narcotics to manufacture medicines and for related scientific purposes only by the Austrian Agency for Health and Food Safety (AGES), or a subsidiary in which it held at least 75 percent. Harvested and dried plants or cannabis could be supplied only to licensed pharmaceutical manufacturers and wholesalers. This created an institutional production route, not a patient home-growing entitlement or general access to cannabis flower.[1][2]
Listed for context. No score change is recorded for Austria here.
References
- Austria — original SMG-Novelle 2008, BGBl. I 143/2008 (RIS)Article I, amendment points 11 and 16; original sections 6(2) and 6a, printed p. 3archived
- Austria — section 6a version and commencement metadata (RIS)In force from 20 December 2008, introduced by BGBl. I 143/2008archived
Checked. The date and the event were compared with a source that was read.